Results 171 to 180 of about 92,786 (217)

Left Ventricular Hypertrophy

Journal of the American Geriatrics Society, 1992
ObjectiveTo review the pathophysiology, epidemiology, patterns, diagnosis, and treatment of left ventricular hypertrophy with emphasis on the elderly.Data SourcesA computer‐assisted search of the English‐language literature (MEDLINE database) followed by a manual search of the bibliographies of pertinent articles.Study SelectionStudies on the ...
openaire   +3 more sources

Left Ventricular Hypertrophy and Arterial Hypertrophy

1997
In the most recent WHO recommendations of 1996 it was reiterated that the classification of HT still remains based on the actual BP figures but also on the importance of target organ lesions. Thus the study of cardiac and vascular function and in particular the presence of hypertrophy or remodeling is of importance.
Jean-Philippe Baguet, J. P. Siche, F. Tremel, Jean-Michel Mallion, R. De Gaudemaris   +4 more
openaire   +3 more sources

Left Ventricular Hypertrophy in Athletes

The American Journal of Cardiology, 1997
Left ventricular wall thickness >1.3 cm, septal-to-posterior wall ratios > 1.5, diastolic left ventricular size >6.0 cm, and eccentric or concentric remodeling are rare in athletes. Values outside of these cutoffs in an athlete of any age probably represent a pathologic state.
W.Douglas B Hiller, Mary L. O'Toole, Sarah E. Katz, R H Laird, Geoffrey S. Ginsburg, Pamela S. Douglas   +5 more
openaire   +3 more sources

Regression of Left Ventricular Hypertrophy

Journal of Cardiovascular Pharmacology, 1992
Since our first studies on hypertrophy regression, this parameter has achieved an increasing interest in the treatment of hypertension. During the past 8 years we studied different groups of antihypertensive drugs with the use of magnetic resonance imaging (MRI). This article discusses the antihypertensive drug carvedilol.
W. Richter, R. J. Schroeder, H. Eichstaedt, W. Auffermann   +3 more
openaire   +3 more sources

Hypertension and Left-Ventricular Hypertrophy

Cardiology Clinics, 1995
Left-ventricular hypertrophy (LVH), the primary cardiac manifestation of hypertension, has been identified as the most powerful risk factor for future cardiovascular events causing morbidity and mortality, such as myocardial infarction, congestive heart failure, sudden death, and so forth.
Franz C. Aepfelbacher, Franz H. Messerli
openaire   +3 more sources

Left ventricular hypertrophy in hypertension

American Heart Journal, 1991
Major advances in left ventricular hypertrophy (LVH) and hypertension have occurred in recent years. The ability to diagnose LVH has been improved by echocardiography, and with this technique it has been shown that evidence of LVH is an important independent risk factor for cardiovascular disease.
R.S. Hornung, Francis G. Dunn, J.M.A. Burns   +2 more
openaire   +3 more sources

Left ventricular hypertrophy and hypertension

Progress in Cardiovascular Diseases, 2020
Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage. In addition to being a marker of HTN, LV geometrical changes: concentric remodeling, concentric or eccentric LV hypertrophy (LVH) are major independent risk factors for not ...
Yildiz, Mehmet, Oktay, Ahmet Afşin, Stewart, Merrill H., Milani, Richard V., Ventura, Hector O., Lavie, Carl J.   +5 more
openaire   +3 more sources

Left Ventricular Hypertrophy

1985
Left ventricular hypertrophy (LVH) is a fundamental component of cardiac adaptation to disorders which alter left ventricular pressure, volume or contractility on a chronic basis. In pressure and volume overload, the LVH response is, initially, quantitatively matched to the increase in hemodynamic load, so that each unit of myocardium performs under ...
Nathaniel Reichek, Martin St. John Sutton   +1 more
openaire   +2 more sources

Genes for left ventricular hypertrophy

Current Hypertension Reports, 2004
Left ventricular (LV) hypertrophy is very common, particularly among hypertensives. The presence of LV hypertrophy profoundly affects morbidity and mortality from cardiovascular diseases and stroke, and is now recognized as the most important predictor of chronic heart failure.
Donna K. Arnett, Lisa de las Fuentes, Ulrich Broeckel   +2 more
openaire   +2 more sources

Cyanosis and Left Ventricular Hypertrophy

Hospital Practice, 1992
(1992). Cyanosis and Left Ventricular Hypertrophy. Hospital Practice: Vol. 27, No. 9, pp. 53-54.
openaire   +3 more sources